Lost Money on Incyte Corporation(INCY)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire • 11/29/24
INCY ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Incyte Corporation investmentAccesswire • 11/26/24
Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual MeetingBusiness Wire • 11/25/24
ATTENTION Incyte Corporation Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your RightsAccesswire • 11/25/24
Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags ChallengesBenzinga • 11/19/24
Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.Investors Business Daily • 11/19/24
Incyte Clocks Mixed Q3 Earnings, But Analyst Sees A Strong Quarter For Jakafi And OpzeluraBenzinga • 10/29/24
INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product SalesZacks Investment Research • 10/29/24
Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical ProgramsBusiness Wire • 10/29/24
Incyte Named One of Top 5 Companies on Science Magazine's 2024 Top Employers ListBusiness Wire • 10/24/24
Incyte Gears Up to Report Q3 Earnings: Here's What You Should KnowZacks Investment Research • 10/22/24